Alpine Global Management, LLC Cytom X Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.19 - $1.91 $42,748 - $68,612	35,923 Added 304.43%	47,723 $76,000
Q3 2022 Nov 14, 2022	BUY	$1.23 - $1.97 $14,514 - $23,246	11,800 New	11,800 $17,000
Q1 2022 May 13, 2022	SELL	$2.67 - $4.68 $27,725 - $48,597	-10,384 Reduced 46.81%	11,800 $32,000
Q4 2021 Feb 14, 2022	BUY	$3.87 - $7.39 $85,852 - $163,939	22,184 New	22,184 $96,000
Q1 2020 Apr 09, 2020	SELL	$3.61 - $8.6 $118,750 - $282,897	-32,895 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$5.17 - $8.91 $170,067 - $293,094	32,895 New	32,895 $273,000

50.2M

22.3K

22.9K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $79.1M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.